- Home
- SRTS vs MNOV Comparison
SRTS vs MNOV Comparison
Compare SRTS & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRTS
- MNOV
- Stock Information
- Founded
- SRTS 2010
- MNOV 2000
- Country
- SRTS United States
- MNOV United States
- Employees
- SRTS N/A
- MNOV N/A
- Industry
- SRTS Medical/Dental Instruments
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- SRTS Health Care
- MNOV Health Care
- Exchange
- SRTS Nasdaq
- MNOV Nasdaq
- Market Cap
- SRTS 75.5M
- MNOV 65.7M
- IPO Year
- SRTS 2016
- MNOV 2005
- Fundamental
- Price
- SRTS $3.39
- MNOV $1.31
- Analyst Decision
- SRTS Strong Buy
- MNOV Strong Buy
- Analyst Count
- SRTS 3
- MNOV 2
- Target Price
- SRTS $8.00
- MNOV $7.00
- AVG Volume (30 Days)
- SRTS 211.1K
- MNOV 63.9K
- Earning Date
- SRTS 08-07-2025
- MNOV 08-14-2025
- Dividend Yield
- SRTS N/A
- MNOV N/A
- EPS Growth
- SRTS N/A
- MNOV N/A
- EPS
- SRTS N/A
- MNOV N/A
- Revenue
- SRTS $37,564,000.00
- MNOV $134,599.00
- Revenue This Year
- SRTS N/A
- MNOV N/A
- Revenue Next Year
- SRTS $33.38
- MNOV N/A
- P/E Ratio
- SRTS N/A
- MNOV N/A
- Revenue Growth
- SRTS 3.29
- MNOV N/A
- 52 Week Low
- SRTS $3.03
- MNOV $1.13
- 52 Week High
- SRTS $9.33
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- SRTS 39.05
- MNOV 48.07
- Support Level
- SRTS $3.08
- MNOV $1.32
- Resistance Level
- SRTS $3.45
- MNOV $1.43
- Average True Range (ATR)
- SRTS 0.20
- MNOV 0.04
- MACD
- SRTS 0.01
- MNOV 0.00
- Stochastic Oscillator
- SRTS 82.00
- MNOV 33.33
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.